MeSH | Haemophilus influenzae type b (D019741)

Haemophilus influenzae type b D019741

Organisms [B] » Bacteria [B03] » Gram-Negative Bacteria » Gram-Negative Facultatively Anaerobic Rods » Pasteurellaceae » Haemophilus » Haemophilus influenzae » Haemophilus influenzae type b

Organisms [B] » Bacteria [B03] » Proteobacteria » Gammaproteobacteria » Pasteurellaceae » Haemophilus » Haemophilus influenzae » Haemophilus influenzae type b

Description

A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis. MeSH

Hierarchy View

View MeSH Tree

Phase 4 Indicated Drugs (11)

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine

dtpa-ipv/hib vaccine

hepatitis b vaccine (recombinant) (recombivax)

hib conjugate vaccine

Phase 3 Indicated Drugs (45)

acellular pertussis vaccine

bivalent oral polio vaccine (bopv), type 1 and type 3

diphtheria toxoid

dtpa-hbv-ipv/hib

haemophilus b conjugate vaccine diphteria crm197 protein conjugate (Menveo)

haemophilus influenzae type b- and meningococcal vaccine

haemophilus influenzae type b conjugate vaccine (PedvaxHIB)

haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine

hepatitis a vaccine, inactivated (vaqta)

hib/hep b vaccine

human rotavirus, live attenuated (Rotarix)

infanrix hexa vaccine

live attenuated varicella vaccine

menacwy conjugate vaccine

meningococcal a&c vaccine

monovalent group c meningococcal vaccine

pneumococcal 13-valent conjugate vaccine (prevnar 13)

pneumococcal 7-valent conjugate vaccine (prevnar)

poliovirus vaccine inactivated

polyribosil-ribitol-phosphate vaccine

Phase 2 Indicated Drugs (12)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

multi-valent pneumococcal conjugate vaccine

polyribosyl ribitol phosphate

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135)

unconjugated hib vaccine

Other Experimental Indicated Drugs (1)

hybrid 5 component dtap, vero ipv, hep b and prp-ompc

Hierarchy Tree View

MeSH

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.